Home / Stocks / CRM

Salesforce (CRM, Application Software) Stock Valuation & Fair Value Mixed on our tests

Salesforce (CRM, Application Software) trades at a blended P/E of 15.3, about 82% below its historical normal valuation, with a forward growth estimate of 7.9% and a PEG of 1.93. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 85.7 on the same blended earnings, the 2026-10-02 close of $234.69 corresponds to about $1,310 a share. This is a valuation reference, not a price target.

Blended P/E
15.3
Normal P/E
85.7
PEG
1.93
Fwd growth
7.9%
Div yield
0.8%
RSI (14)
47.0
Neutral
Technical context
  • Price $227.80 at the 2026-10-08 close, 3.7% below the 20-day average ($236.63) and 1.8% above the 50-day ($223.80).
  • RSI (14) at 47.0.
  • 52-week range $149.86 to $264.42: the price is 13.8% below the high and 52.0% above the low.

The Street vs SeerForecast

Wall Street's mean price target for CRM is $283.36 across 54 analysts, 24.4% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from favorable on our tests (2026-06-03) to mixed on our tests (2026-10-05).

Blended P/E and rating by weekBlended P/E moved from 13.5 to 15.3 between 2026-06-03 and 2026-10-02, against a normal P/E of 85.7, with 1 rating change over 37 recorded weeks.2026-06-03: P/E 13.5, Favorable on our tests, recalculated for the week of 2026-06-032026-06-10: P/E 14.2, Favorable on our tests, recalculated for the week of 2026-06-102026-06-12: P/E 14.2, Favorable on our tests, recalculated for the week of 2026-06-142026-06-16: P/E 14.2, Favorable on our tests, recalculated for the week of 2026-06-162026-06-18: P/E 14.2, Favorable on our tests, recalculated for the week of 2026-06-212026-07-02: P/E 12.4, Favorable on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 12.6, Favorable on our tests, recalculated for the week of 2026-07-062026-07-09: P/E 12.6, Favorable on our tests, recalculated for the week of 2026-07-092026-07-10: P/E 12.4, Favorable on our tests, recalculated for the week of 2026-07-122026-07-13: P/E 12.4, Favorable on our tests, recalculated for the week of 2026-07-132026-07-14: P/E 12.4, Favorable on our tests, recalculated for the week of 2026-07-142026-07-20: P/E 12.9, Favorable on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 12.9, Favorable on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 12.3, Favorable on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 12.3, Favorable on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 13.6, Favorable on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 13.8, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 14.0, Favorable on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 14.4, Favorable on our tests, recorded live 2026-08-102026-08-14: P/E 15.1, Favorable on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 14.7, Favorable on our tests, recorded live 2026-08-172026-08-21: P/E 15.3, Favorable on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 15.6, Favorable on our tests, recorded live 2026-08-242026-08-27: P/E 15.6, Favorable on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 16.9, Mixed on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 17.2, Mixed on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 17.2, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 17.3, Mixed on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 17.3, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 16.4, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 16.4, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 15.7, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 15.7, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 15.4, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 15.4, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 15.3, Mixed on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 15.3, Mixed on our tests, recorded live 2026-10-0520.040.060.080.0Jun 3Jul 3Aug 2Sep 2Oct 2Normal P/E 85.7
Favorable on our testsMixed on our tests

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 13.5not meaningfulFavorable on our tests (recalculated)
2026-07-25P/E 12.3not meaningfulFavorable on our tests (recalculated)
2026-08-28P/E 16.9-80%Mixed on our tests (recalculated)
2026-09-05P/E 17.3-80%Mixed on our tests (recalculated)
2026-10-05P/E 15.3-82%Mixed on our tests ← now
Show all 37 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 13.5not meaningfulFavorable on our tests (recalculated)
2026-06-10P/E 14.2not meaningfulFavorable on our tests (recalculated)
2026-06-14P/E 14.2not meaningfulFavorable on our tests (recalculated)
2026-06-16P/E 14.2not meaningfulFavorable on our tests (recalculated)
2026-06-21P/E 14.2not meaningfulFavorable on our tests (recalculated)
2026-07-02P/E 12.4not meaningfulFavorable on our tests (recalculated)
2026-07-06P/E 12.6not meaningfulFavorable on our tests (recalculated)
2026-07-09P/E 12.6not meaningfulFavorable on our tests (recalculated)
2026-07-12P/E 12.4not meaningfulFavorable on our tests (recalculated)
2026-07-13P/E 12.4not meaningfulFavorable on our tests (recalculated)
2026-07-14P/E 12.4not meaningfulFavorable on our tests (recalculated)
2026-07-20P/E 12.9not meaningfulFavorable on our tests (recalculated)
2026-07-22P/E 12.9not meaningfulFavorable on our tests (recalculated)
2026-07-25P/E 12.3not meaningfulFavorable on our tests (recalculated)
2026-07-27P/E 12.3not meaningfulFavorable on our tests (recalculated)
2026-07-31P/E 13.6not meaningfulFavorable on our tests (recalculated)
2026-08-03P/E 13.8not meaningfulFavorable on our tests
2026-08-07P/E 14.0not meaningfulFavorable on our tests (recalculated)
2026-08-10P/E 14.4-83%Favorable on our tests
2026-08-14P/E 15.1-82%Favorable on our tests (recalculated)
2026-08-17P/E 14.7-83%Favorable on our tests
2026-08-21P/E 15.3-82%Favorable on our tests (recalculated)
2026-08-24P/E 15.6-82%Favorable on our tests
2026-08-27P/E 15.6-82%Favorable on our tests (recalculated)
2026-08-28P/E 16.9-80%Mixed on our tests (recalculated)
2026-08-30P/E 17.2-80%Mixed on our tests (recalculated)
2026-08-31P/E 17.2-80%Mixed on our tests
2026-09-05P/E 17.3-80%Mixed on our tests (recalculated)
2026-09-07P/E 17.3-80%Mixed on our tests
2026-09-12P/E 16.4-81%Mixed on our tests (recalculated)
2026-09-14P/E 16.4-81%Mixed on our tests
2026-09-19P/E 15.7-82%Mixed on our tests (recalculated)
2026-09-21P/E 15.7-82%Mixed on our tests
2026-09-26P/E 15.4-82%Mixed on our tests (recalculated)
2026-09-28P/E 15.4-82%Mixed on our tests
2026-10-03P/E 15.3-82%Mixed on our tests (recalculated)
2026-10-05P/E 15.3-82%Mixed on our tests ← now

Frequently asked questions

Is Salesforce stock overvalued?

At a blended P/E of 15.3 versus its historical normal P/E of 85.7, Salesforce trades about 82% below its typical valuation, with a PEG of 1.93 on 7.9% forward growth. tickerseer currently rates it mixed on our tests.

What is Salesforce's fair value and PEG?

Salesforce trades at a blended P/E of 15.3 against a historical normal P/E of 85.7, a PEG of 1.93, and a forward growth estimate of 7.9%. Priced at its historical normal P/E of 85.7 on the same blended earnings, the 2026-10-02 close of $234.69 corresponds to about $1,310 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Salesforce changed?

tickerseer's rating moved from favorable on our tests (2026-06-03) to mixed on our tests (2026-10-05).

What is the analyst price target for Salesforce?

The mean Wall Street price target for Salesforce is $283.36 across 54 analysts, 24.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Application Software. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.